Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Paola S. Dal Cin, Ph.D.

Co-Author

This page shows the publications co-authored by Paola Dal Cin and Adrian Dubuc.
Connection Strength

1.206
  1. FISHing in the dark: How the combination of FISH and conventional karyotyping improves the diagnostic yield in CpG-stimulated chronic lymphocytic leukemia. Am J Hematol. 2016 10; 91(10):978-83.
    View in: PubMed
    Score: 0.671
  2. Twists and turns from "tumor in tumor" profiling: surveillance of chronic lymphocytic leukemia (CLL) leads to detection of a lung adenocarcinoma, whose genomic characterization alters the original hematologic diagnosis. Cold Spring Harb Mol Case Stud. 2021 08; 7(4).
    View in: PubMed
    Score: 0.238
  3. Guiding the Global Evolution of Cytogenetic Testing for Hematologic Malignancies. Blood. 2022 Feb 15.
    View in: PubMed
    Score: 0.062
  4. Clinical response to larotrectinib in adult Philadelphia chromosome-like ALL with cryptic ETV6-NTRK3 rearrangement. Blood Adv. 2020 01 14; 4(1):106-111.
    View in: PubMed
    Score: 0.053
  5. Molecular characterization of localized pleural mesothelioma. Mod Pathol. 2020 02; 33(2):271-280.
    View in: PubMed
    Score: 0.052
  6. ZMYM2-FGFR1 fusion as secondary change in acute myeloid leukemia. Leuk Lymphoma. 2019 02; 60(2):556-558.
    View in: PubMed
    Score: 0.049
  7. Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition. Nat Commun. 2016 05 20; 7:11589.
    View in: PubMed
    Score: 0.041
  8. Reporting of Diagnostic Cytogenetic Results. Curr Protoc Hum Genet. 2016 Apr 01; 89:A.1D.1-A.1D.23.
    View in: PubMed
    Score: 0.041
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.